MedTrace Logo

Hearing Screening Outcomes of Two Screening Tests in Newborns of Gestational Diabetic Mothers

NCT04845412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2021-04-19

No results posted yet for this study

Summary

In this study, the investigators have aimed to investigate whether GDM is a risk factor for hearing impairment in newborns. To the investigators knowledge, this study is the first prospective, controlled study on this subject.

Conditions

Interventions

DIAGNOSTIC_TEST

Hearing screening tests

Our study was conducted in accordance with the National Hearing Screening Test Protocol. The newborns had transient evoked otoacoustic emissions (TEOAE) with "click" stimulus as a hearing screening test in the first three days after birth, using Otometrics Madsen Accuscreen S/N: 36484 (USA) device.

Sponsors & Collaborators

  • Ankara Training and Research Hospital

    lead OTHER

Principal Investigators

  • Esra Gulen Yildiz · Ankara Training and Resarch Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-06-01
Completion
2020-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04845412 on ClinicalTrials.gov